07:00 , Sep 10, 2015 |  BC Innovations  |  Tools & Techniques

Undiscovered country

Although total RNA sequencing can identify oncogenes caused by the fusion of two genes, the method is inefficient and costly because the transcripts from the abnormal genes are often rare. NuGen Technologies Inc. has developed...
07:00 , Sep 24, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) Clusterin (CLU; APOJ); phosphatidylinositol-binding clathrin assembly protein (PICALM) A genomewide association study suggests that CLU and PICALM could be risk markers for...